1Vischetti M, Zito F, Benedetta D M, et al. Licia Lacoviello. Analysis of gene enviroment interaction in coronary heart disease: fibrinogen polymorpbisms as an exarnple. Ital Heart J,2002,3: 18-23.
2Jousilahti P, Salomaa V, Rasi V, et al. Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status. J Epidemiol Community Health, 2003,57: 730-733.
3Davey Smith G, Ebrahim S. Mendelian randomization, can genetic epidemiology contribute to understanding environmental determinants of disease.Int J Epidemiol, 2003,32: 1-22.
4Ernst E. Fibrinogen as a cardiovascular risk analysis and revie of the literature. Ann Inter Med, 1993,118: 956-963.
5Levenson J. Fibrinogen and silent atherosclerosis in subject with vascular risk factors. Arteriscler Thromb vasc Biol, 1995,15 : 1263-1268.
6Levenson J, Giral P, Megnine JL, et al. Fibrinogen and its relation to subclinical extracoronary and atherosclerosis in hypercholesterolemic men. Arterioscler Thromb Vasc Biol, 1997,17:45-50.
4Lorig K,Sobel D,Stewart A,et al.Evidence suggesting that a chronic disease self-management programme improve health status while reducing hospitalization:a randomized trial.Medi Care,1999,37:5-14.
